Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 17/20 | 0.58 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 6/20 | 0.58 |
| ▸ | PIK3CB | P42338 | 5/20 | 0.58 |
| ▸ | AKT1 | P31749 | 5/20 | 0.57 |
| ▸ | PIK3R1 | P27986 | 4/20 | 0.54 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.54 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.51 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.49 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10327617 | 0.91 | PIK3CA (0.54) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL13848170 | 0.91 | PIK3CA (0.60) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL10327593 | 0.89 | PIK3CA (0.59) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL4115358 | 0.89 | PIK3CA (0.55) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL3990974 | 0.88 | PIK3CA (0.62) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL10328308 | 0.87 | MTOR (0.60) | PIK3CAMTORPIK3CBAKT1PIK3R1 | |
| SCHEMBL13848004 | 0.86 | PIK3CA (0.70) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL4110129 | 0.86 | PIK3CA (0.57) | PIK3CAMAP3K12MTORPIK3CBAKT1 | |
| SCHEMBL10328139 | 0.85 | PIK3CA (0.62) | PIK3CAMTORPIK3CBPIK3R1PIK3CD | |
| SCHEMBL15014988 | 0.85 | PIK3CA (0.54) | PIK3CAMTORPIK3CBPIK3R1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009066084-A1 | 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-28 | — | — | WO | claimed |
| US-8563549-B2 | Pyrimidine derivatives used as PI-3 kinase inhibitors | NOVARTIS AG (CH) | 2013-10-22 | — | — | US | disclosed |
| US-8563549-B2 | Pyrimidine derivatives used as PI-3 kinase inhibitors | NOVARTIS AG (CH) | 2013-10-22 | — | — | US | disclosed |
| WO-2009066084-A1 | 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-28 | — | — | WO | disclosed |